Want to see BCLI full AI Analyst Report?
Brainstorm Cell Therapeutics (BCLI) Q2 2026 Earnings Report
BCLI Q2 2026 EPS Results
- Actual EPS
- -$0.35
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.34
BCLI Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/14/2026
- Time
- After Close
- Conference Call
- Friday, August 14, 2026
BCLI Upcoming Earnings
Brainstorm Cell Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
BCLI Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -0.18- | -0.19 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | ―-0.35 | -0.34 | -2.94% (-0.01) | |
| May 15, 2026 | 2026 (Q1) | ―-0.19 | -0.45 | 57.78% (+0.26) | |
| Mar 31, 2026 | 2025 (Q4) | -0.28-0.19 | -0.45 | 57.78% (+0.26) | |
| Nov 14, 2025 | 2025 (Q3) | -0.37-0.19 | -0.51 | 62.75% (+0.32) | |
| Aug 14, 2025 | 2025 (Q2) | -0.37-0.34 | 0.6 | -156.67% (-0.94) | |
| May 16, 2025 | 2025 (Q1) | ―-0.45 | -0.75 | 40.00% (+0.30) | |
| Mar 31, 2025 | 2024 (Q4) | -0.97-0.45 | -0.75 | 40.00% (+0.30) | |
| Nov 14, 2024 | 2024 (Q3) | -0.57-0.51 | -0.45 | -13.33% (-0.06) | |
| Aug 14, 2024 | 2024 (Q2) | -0.530.60 | -1.95 | 130.77% (+2.55) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
